{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:49:40Z","timestamp":1788565780763,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T00:00:00Z","timestamp":1550448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T00:00:00Z","timestamp":1550448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874107"],"award-info":[{"award-number":["81874107"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572554"],"award-info":[{"award-number":["81572554"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81502245"],"award-info":[{"award-number":["81502245"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Program for Interdisciplinary Basic Research of Shandong University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>High-grade serous ovarian carcinoma (HGSOC) is the most lethal type of gynecologic malignancy. Chemoresistance is the main reason for the poor prognosis of HGSOC. PDZ-binding kinase (PBK) promotes the malignant progression of various carcinomas. However, the roles and clinical significance of PBK in HGSOC remain unclear. Here, we reported that PBK was overexpressed in HGSOC tissues and cell lines. High PBK expression was associated with a poor prognosis, metastasis, and cisplatin resistance of HGSOC. Overexpression of PBK promoted autophagy and enhanced cisplatin resistance via the ERK\/mTOR signaling pathway. Further study showed that inhibition of autophagy by chloroquine or bafilomycin A1 reversed PBK-induced cisplatin resistance. Overexpression of PBK decreased ovarian cancer responsiveness to cisplatin treatment through inducing autophagy in vivo. We also demonstrated that the PBK inhibitor OTS514 augmented the growth inhibition effect of cisplatin in vitro and in vivo. Moreover, ecotropic viral integration site-1 (EVI1) could regulate PBK expression through directly targeting the PBK promoter region. In conclusion, high PBK expression was correlated with a poor prognosis, metastasis, and cisplatin resistance through promoting autophagy in HGSOC. PBK might be a promising target for the early diagnosis and individual treatment of ovarian cancer.<\/jats:p>","DOI":"10.1038\/s41419-019-1415-6","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T04:04:51Z","timestamp":1550462691000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["PBK, targeted by EVI1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinoma"],"prefix":"10.1038","volume":"10","author":[{"given":"Hanlin","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonghua","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cunzhong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beihua","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,18]]},"reference":[{"key":"1415_CR1","doi-asserted-by":"publisher","first-page":"viii1","DOI":"10.1093\/annonc\/mdx444","volume":"28","author":"K Odunsi","year":"2017","unstructured":"Odunsi, K. Immunotherapy in ovarian cancer. Ann. Oncol. 28, viii1\u2013viii7 (2017).","journal-title":"Ann. Oncol."},{"key":"1415_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2018. CA Cancer J. Clin. 68, 7\u201330 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"1415_CR3","doi-asserted-by":"publisher","first-page":"R303","DOI":"10.1530\/ERC-17-0336","volume":"25","author":"B van Zyl","year":"2018","unstructured":"van Zyl, B., Tang, D. & Bowden, N. A. Biomarkers of platinum resistance in ovarian cancer: what can we use to improve treatment. Endocr. Relat. Cancer 25, R303\u2013R318 (2018).","journal-title":"Endocr. Relat. Cancer"},{"key":"1415_CR4","doi-asserted-by":"publisher","first-page":"viii13","DOI":"10.1093\/annonc\/mdx446","volume":"28","author":"EL Christie","year":"2017","unstructured":"Christie, E. L. & Bowtell, D. D. L. Acquired chemotherapy resistance in ovarian cancer. Ann. Oncol. 28, viii13\u2013viii15 (2017).","journal-title":"Ann. Oncol."},{"key":"1415_CR5","doi-asserted-by":"publisher","first-page":"21525","DOI":"10.1074\/jbc.M909629199","volume":"275","author":"Y Abe","year":"2000","unstructured":"Abe, Y., Matsumoto, S., Kito, K. & Ueda, N. Cloning and expression of a novel MAPKK-like protein kinase, lymphokine-activated killer T-cell-originated protein kinase, specifically expressed in the testis and activated lymphoid cells. J. Biol. Chem. 275, 21525\u201321531 (2000).","journal-title":"J. Biol. Chem."},{"key":"1415_CR6","doi-asserted-by":"publisher","first-page":"10773","DOI":"10.1523\/JNEUROSCI.3207-05.2005","volume":"25","author":"JD Dougherty","year":"2005","unstructured":"Dougherty, J. D. et al. PBK\/TOPK, a proliferating neural progenitor-specific mitogen-activated protein kinase kinase. J. Neurosci. 25, 10773\u201310785 (2005).","journal-title":"J. Neurosci."},{"key":"1415_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jmb.2007.04.067","volume":"370","author":"Y Abe","year":"2007","unstructured":"Abe, Y. et al. A mitotic kinase TOPK enhances Cdk1\/cyclin B1-dependent phosphorylation of PRC1 and promotes cytokinesis. J. Mol. Biol. 370, 231\u2013245 (2007).","journal-title":"J. Mol. Biol."},{"key":"1415_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1131-7","volume":"9","author":"KJ Herbert","year":"2018","unstructured":"Herbert, K. J., Ashton, T. M., Prevo, R., Pirovano, G. & Higgins, G. S. T-LAKcell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics. Cell Death Dis. 9, 1089 (2018).","journal-title":"Cell Death Dis."},{"key":"1415_CR9","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/bjc.2016.394","volume":"116","author":"T Ohashi","year":"2017","unstructured":"Ohashi, T. et al. Overexpression of PBK\/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma. Br. J. Cancer 116, 218\u2013226 (2017).","journal-title":"Br. J. Cancer"},{"key":"1415_CR10","doi-asserted-by":"crossref","unstructured":"Chang, C. F. et al. PBK\/TOPK expression predicts prognosis in oral cancer. Int. J. Mol. Sci. 17, 1007 (2016).","DOI":"10.3390\/ijms17071007"},{"key":"1415_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-015-0398-x","volume":"14","author":"M Joel","year":"2015","unstructured":"Joel, M. et al. Targeting PBK\/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo. Mol. Cancer 14, 121 (2015).","journal-title":"Mol. Cancer"},{"key":"1415_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.humpath.2014.07.026","volume":"46","author":"B Lei","year":"2015","unstructured":"Lei, B. et al. PBK\/TOPK expression correlates with mutant p53 and affects patients\u2019 prognosis and cell proliferation and viability in lung adenocarcinoma. Hum. Pathol. 46, 217\u2013224 (2015).","journal-title":"Hum. Pathol."},{"key":"1415_CR13","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1038\/onc.2011.419","volume":"31","author":"MC Shih","year":"2012","unstructured":"Shih, M. C. et al. TOPK\/PBK promotes cell migration via modulation of the PI3K\/PTEN\/AKT pathway and is associated with poor prognosis in lung cancer. Oncogene 31, 2389\u20132400 (2012).","journal-title":"Oncogene"},{"key":"1415_CR14","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1158\/0008-5472.CAN-11-3851","volume":"72","author":"DJ Kim","year":"2012","unstructured":"Kim, D. J. et al. Novel TOPK inhibitor HI-TOPK-032 effectively suppresses colon cancer growth. Cancer Res. 72, 3060\u20133068 (2012).","journal-title":"Cancer Res."},{"key":"1415_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/sj.bjc.6605452","volume":"102","author":"I Zlobec","year":"2010","unstructured":"Zlobec, I. et al. Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients. Br. J. Cancer 102, 151\u2013161 (2010).","journal-title":"Br. J. Cancer"},{"key":"1415_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1053\/j.gastro.2007.04.048","volume":"133","author":"F Zhu","year":"2007","unstructured":"Zhu, F. et al. Bidirectional signals transduced by TOPK-ERK interaction increase tumorigenesis of HCT116 colorectal cancer cells. Gastroenterology 133, 219\u2013231 (2007).","journal-title":"Gastroenterology"},{"key":"1415_CR17","doi-asserted-by":"publisher","first-page":"9186","DOI":"10.1158\/0008-5472.CAN-06-1601","volume":"66","author":"JH Park","year":"2006","unstructured":"Park, J. H., Lin, M. L., Nishidate, T., Nakamura, Y. & Katagiri, T. PDZ-binding kinase\/T-LAK cell-originated protein kinase, a putative cancer\/testis antigen with an oncogenic activity in breast cancer. Cancer Res. 66, 9186\u20139195 (2006).","journal-title":"Cancer Res."},{"key":"1415_CR18","doi-asserted-by":"publisher","first-page":"15594","DOI":"10.18632\/oncotarget.3709","volume":"6","author":"JD Brown-Clay","year":"2015","unstructured":"Brown-Clay, J. D. et al. PBK\/TOPK enhances aggressive phenotype in prostate cancer via beta-catenin-TCF\/LEF-mediated matrix metalloproteinases production and invasion. Oncotarget 6, 15594\u201315609 (2015).","journal-title":"Oncotarget"},{"key":"1415_CR19","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1093\/carcin\/bgy114","volume":"39","author":"CP Hinzman","year":"2018","unstructured":"Hinzman, C. P. et al. Aberrant expression of PDZ-binding kinase\/T-LAK cell-originated protein kinase modulates the invasive ability of human pancreatic cancer cells via the stabilization of oncoprotein c-MYC. Carcinogenesis 39, 1548\u20131559 (2018).","journal-title":"Carcinogenesis"},{"key":"1415_CR20","doi-asserted-by":"crossref","unstructured":"Warren, A. Y. et al. A reciprocal feedback between the PDZ binding kinase and androgen receptor drives prostate cancer. Oncogene 38, 1136\u20131150 (2018).","DOI":"10.1038\/s41388-018-0501-z"},{"key":"1415_CR21","doi-asserted-by":"publisher","first-page":"6110","DOI":"10.1158\/1078-0432.CCR-16-0207","volume":"22","author":"Y Ikeda","year":"2016","unstructured":"Ikeda, Y. et al. T-LAK Cell-Originated Protein Kinase (TOPK) as a prognostic factor and a potential therapeutic target in ovarian cancer. Clin. Cancer Res. 22, 6110\u20136117 (2016).","journal-title":"Clin. Cancer Res."},{"key":"1415_CR22","doi-asserted-by":"crossref","unstructured":"Gao, T. et al. Novel selective TOPK inhibitor SKLB-C05 inhibits colorectal carcinoma growth and metastasis. Cancer Lett. 445, 11\u201323 (2018).","DOI":"10.1016\/j.canlet.2018.12.016"},{"key":"1415_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1146\/annurev-cellbio-092910-154005","volume":"27","author":"N Mizushima","year":"2011","unstructured":"Mizushima, N., Yoshimori, T. & Ohsumi, Y. The role of Atg proteins in autophagosome formation. Annu. Rev. Cell Dev. Biol. 27, 107\u2013132 (2011).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"1415_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41580-018-0003-4","volume":"19","author":"I Dikic","year":"2018","unstructured":"Dikic, I. & Elazar, Z. Mechanism and medical implications of mammalian autophagy. Nat. Rev. Mol. Cell Biol. 19, 349\u2013364 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1415_CR25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.canlet.2011.03.026","volume":"307","author":"G Xi","year":"2011","unstructured":"Xi, G. et al. Autophagy inhibition promotes paclitaxel-induced apoptosis in cancer cells. Cancer Lett. 307, 141\u2013148 (2011).","journal-title":"Cancer Lett."},{"key":"1415_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0658-y","volume":"9","author":"TW Kim","year":"2018","unstructured":"Kim, T. W. et al. DSGOST regulates resistance via activation of autophagy in gastric cancer. Cell Death Dis. 9, 649 (2018).","journal-title":"Cell Death Dis."},{"key":"1415_CR27","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1002\/ijc.31535","volume":"143","author":"KK Chan","year":"2018","unstructured":"Chan, K. K. et al. Impact of iASPP on chemoresistance through PLK1 and autophagy in ovarian clear cell carcinoma. Int. J. Cancer 143, 1456\u20131469 (2018).","journal-title":"Int. J. Cancer"},{"key":"1415_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.bbrc.2017.03.162","volume":"488","author":"J Zou","year":"2017","unstructured":"Zou, J., Kuang, W., Hu, J. & Rao, H. miR-216b promotes cell growth and enhances chemosensitivity of colorectal cancer by suppressing PDZ-binding kinase. Biochem. Biophys. Res. Commun. 488, 247\u2013252 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1415_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.116","volume":"8","author":"HC Lee","year":"2017","unstructured":"Lee, H. C. et al. Radiation-inducible miR-770-5p sensitizes tumors to radiation through direct targeting of PDZ-binding kinase. Cell Death Dis. 8, e2693 (2017).","journal-title":"Cell Death Dis."},{"key":"1415_CR30","doi-asserted-by":"publisher","first-page":"7782","DOI":"10.18632\/oncotarget.23674","volume":"9","author":"C Quan","year":"2018","unstructured":"Quan, C. et al. T-lymphokine-activated killer cell-originated protein kinase (TOPK) as a prognostic factor and a potential therapeutic target in glioma. Oncotarget 9, 7782\u20137795 (2018).","journal-title":"Oncotarget"},{"key":"1415_CR31","doi-asserted-by":"publisher","first-page":"5464","DOI":"10.1038\/onc.2010.275","volume":"29","author":"F Hu","year":"2010","unstructured":"Hu, F. et al. PBK\/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21. Oncogene 29, 5464\u20135474 (2010).","journal-title":"Oncogene"},{"key":"1415_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-2-34","volume":"2","author":"M Li","year":"2009","unstructured":"Li, M. et al. Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer. BMC Med. Genomics 2, 34 (2009).","journal-title":"BMC Med. Genomics"},{"key":"1415_CR33","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","volume":"36","author":"MC Mendoza","year":"2011","unstructured":"Mendoza, M. C., Er, E. E. & Blenis, J. The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. Trends Biochem. Sci. 36, 320\u2013328 (2011).","journal-title":"Trends Biochem. Sci."},{"key":"1415_CR34","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/35044114","volume":"408","author":"Y Ichimura","year":"2000","unstructured":"Ichimura, Y. et al. A ubiquitin-like system mediates protein lipidation. Nature 408, 488\u2013492 (2000).","journal-title":"Nature"},{"key":"1415_CR35","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1083\/jcb.200412022","volume":"169","author":"M Komatsu","year":"2005","unstructured":"Komatsu, M. et al. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J. Cell Biol. 169, 425\u2013434 (2005).","journal-title":"J. Cell Biol."},{"key":"1415_CR36","doi-asserted-by":"crossref","first-page":"26604","DOI":"10.18632\/oncotarget.8445","volume":"7","author":"MY Wang","year":"2016","unstructured":"Wang, M. Y. et al. PDZ binding kinase (PBK) is a theranostic target for nasopharyngeal carcinoma: driving tumor growth via ROS signaling and correlating with patient survival. Oncotarget 7, 26604\u201326616 (2016).","journal-title":"Oncotarget"},{"key":"1415_CR37","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ijbiomac.2015.08.048","volume":"81","author":"JH Chen","year":"2015","unstructured":"Chen, J. H. et al. Overexpression of PDZ-binding kinase confers malignant phenotype in prostate cancer via the regulation of E2F1. Int. J. Biol. Macromol. 81, 615\u2013623 (2015).","journal-title":"Int. J. Biol. Macromol."},{"key":"1415_CR38","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1038\/sj.onc.1210142","volume":"26","author":"V Ayllon","year":"2007","unstructured":"Ayllon, V. & O\u2019Connor, R. PBK\/TOPK promotes tumour cell proliferation through p38 MAPK activity and regulation of the DNA damage response. Oncogene 26, 3451\u20133461 (2007).","journal-title":"Oncogene"},{"key":"1415_CR39","doi-asserted-by":"publisher","first-page":"5167","DOI":"10.1073\/pnas.090102397","volume":"97","author":"S Gaudet","year":"2000","unstructured":"Gaudet, S., Branton, D. & Lue, R. A. Characterization of PDZ-binding kinase, a mitotic kinase. Proc. Natl Acad. Sci. USA 97, 5167\u20135172 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1415_CR40","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1101\/gad.287524.116","volume":"30","author":"R Amaravadi","year":"2016","unstructured":"Amaravadi, R., Kimmelman, A. C. & White, E. Recent insights into the function of autophagy in cancer. Genes Dev. 30, 1913\u20131930 (2016).","journal-title":"Genes Dev."},{"key":"1415_CR41","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrc3262","volume":"12","author":"E White","year":"2012","unstructured":"White, E. Deconvoluting the context-dependent role for autophagy in cancer. Nat. Rev. Cancer 12, 401\u2013410 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"1415_CR42","doi-asserted-by":"publisher","first-page":"509","DOI":"10.4161\/auto.7.5.15066","volume":"7","author":"TR O\u2019Donovan","year":"2011","unstructured":"O\u2019Donovan, T. R., O\u2019Sullivan, G. C. & McKenna, S. L. Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics. Autophagy 7, 509\u2013524 (2011).","journal-title":"Autophagy"},{"key":"1415_CR43","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.1074\/jbc.M111.307405","volume":"287","author":"Z Zou","year":"2012","unstructured":"Zou, Z. et al. MicroRNA-30a sensitizes tumor cells to cis-platinum via suppressing beclin 1-mediated autophagy. J. Biol. Chem. 287, 4148\u20134156 (2012).","journal-title":"J. Biol. Chem."},{"key":"1415_CR44","doi-asserted-by":"publisher","first-page":"17163","DOI":"10.1074\/jbc.M114.558288","volume":"289","author":"J Wang","year":"2014","unstructured":"Wang, J. & Wu, G. S. Role of autophagy in cisplatin resistance in ovarian cancer cells. J. Biol. Chem. 289, 17163\u201317173 (2014).","journal-title":"J. Biol. Chem."},{"key":"1415_CR45","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.18632\/oncotarget.6826","volume":"7","author":"Y Li","year":"2016","unstructured":"Li, Y. et al. TOPK promotes lung cancer resistance to EGFR tyrosine kinase inhibitors by phosphorylating and activating c-Jun. Oncotarget 7, 6748\u20136764 (2016).","journal-title":"Oncotarget"},{"key":"1415_CR46","doi-asserted-by":"publisher","first-page":"259ra145","DOI":"10.1126\/scitranslmed.3010277","volume":"6","author":"Y Matsuo","year":"2014","unstructured":"Matsuo, Y. et al. TOPK inhibitor induces complete tumor regression in xenograft models of human cancer through inhibition of cytokinesis. Sci. Transl. Med 6, 259ra145 (2014).","journal-title":"Sci. Transl. Med"},{"key":"1415_CR47","doi-asserted-by":"publisher","first-page":"33410","DOI":"10.18632\/oncotarget.5418","volume":"6","author":"H Alachkar","year":"2015","unstructured":"Alachkar, H. et al. T-LAK cell-originated protein kinase presents a novel therapeutic target in FLT3-ITD mutated acute myeloid leukemia. Oncotarget 6, 33410\u201333425 (2015).","journal-title":"Oncotarget"},{"key":"1415_CR48","doi-asserted-by":"crossref","first-page":"17652","DOI":"10.18632\/oncotarget.7755","volume":"7","author":"T Kato","year":"2016","unstructured":"Kato, T. et al. Oncogenic roles of TOPK and MELK, and effective growth suppression by small molecular inhibitors in kidney cancer cells. Oncotarget 7, 17652\u201317664 (2016).","journal-title":"Oncotarget"},{"key":"1415_CR49","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.leukres.2005.08.011","volume":"30","author":"AK Nandi","year":"2006","unstructured":"Nandi, A. K. & Rapoport, A. P. Expression of PDZ-binding kinase (PBK) is regulated by cell cycle-specific transcription factors E2F and CREB\/ATF. Leuk. Res. 30, 437\u2013447 (2006).","journal-title":"Leuk. Res."},{"key":"1415_CR50","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.leukres.2012.11.010","volume":"37","author":"F Hu","year":"2013","unstructured":"Hu, F. et al. c-Myc and E2F1 drive PBK\/TOPK expression in high-grade malignant lymphomas. Leuk. Res. 37, 447\u2013454 (2013).","journal-title":"Leuk. Res."},{"key":"1415_CR51","doi-asserted-by":"crossref","first-page":"47195","DOI":"10.18632\/oncotarget.17587","volume":"8","author":"YF Yang","year":"2017","unstructured":"Yang, Y. F. et al. PDZ binding kinase, regulated by FoxM1, enhances malignant phenotype via activation of beta-Catenin signaling in hepatocellular carcinoma. Oncotarget 8, 47195\u201347205 (2017).","journal-title":"Oncotarget"},{"key":"1415_CR52","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1158\/0008-5472.CAN-06-2366","volume":"67","author":"M Nanjundan","year":"2007","unstructured":"Nanjundan, M. et al. Amplification of MDS1\/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer. Cancer Res. 67, 3074\u20133084 (2007).","journal-title":"Cancer Res."},{"key":"1415_CR53","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1038\/bjc.1996.583","volume":"74","author":"DJ Brooks","year":"1996","unstructured":"Brooks, D. J. et al. Expression of the zinc finger gene EVI-1 in ovarian and other cancers. Br. J. Cancer 74, 1518\u20131525 (1996).","journal-title":"Br. J. Cancer"},{"key":"1415_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-9-368","volume":"9","author":"L Osterberg","year":"2009","unstructured":"Osterberg, L. et al. Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas. BMC Cancer 9, 368 (2009).","journal-title":"BMC Cancer"},{"key":"1415_CR55","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1021\/cb100153r","volume":"5","author":"L Su","year":"2010","unstructured":"Su, L. et al. Role of Hmbox1 in endothelial differentiation of bone-marrow stromal cells by a small molecule. ACS Chem. Biol. 5, 1035\u20131043 (2010).","journal-title":"ACS Chem. Biol."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1415-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1415-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1415-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T11:34:04Z","timestamp":1671190444000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1415-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,18]]},"references-count":55,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3]]}},"alternative-id":["1415"],"URL":"https:\/\/doi.org\/10.1038\/s41419-019-1415-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,18]]},"assertion":[{"value":"26 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"166"}}